phenylalanine has been researched along with Neoplasms in 164 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 86 (52.44) | 18.7374 |
1990's | 19 (11.59) | 18.2507 |
2000's | 20 (12.20) | 29.6817 |
2010's | 25 (15.24) | 24.3611 |
2020's | 14 (8.54) | 2.80 |
Authors | Studies |
---|---|
Nishimori, I; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Afzal, S; Channar, PA; Ejaz, SA; Erben, MF; Iqbal, J; Larik, FA; Lecka, J; Mahesar, PA; Saeed, A; Sévigny, J | 1 |
Chien, HC; Colas, C; Giacomini, KM; Hall, C; Schlessinger, A; Thomas, AA; Wells, A; Wolfe, H | 1 |
Lehmann, F; Lindberg, J; Nilvebrant, J; Nygren, PÅ | 1 |
Fukuda, H | 1 |
Agami, R; Altelaar, M; Bassani-Sternberg, M; Bleijerveld, OB; Blommaert, N; Champagne, J; de Gooijer, MC; Georgiou, G; Joosten, RP; Kenski, J; Laos, M; Lovecchio, D; Michaux, J; Mordente, K; Nagel, R; Navarro, JM; Nielsen, MM; Olweus, J; Pak, HS; Pataskar, A; Peeper, DS; Perrakis, A; Stone, E; van Tellingen, O | 1 |
Ahmad, SM; Bhagat, M; Faheem, MM; Goswami, A; Kaur, G; Mir, KB; Rahim, JU; Rai, R | 1 |
Marnani, MB; Oftadeh, M; Sohrabi, N | 1 |
Chmiela, M; Gonciarz, W; Pająk, M; Sutradhar, M; Woźniczka, M | 1 |
Hirano, F; Kondo, N; Murata, Y; Sudani, A; Temma, T | 1 |
Chen, H; Duan, K; Guo, J; Li, R; Wan, H; Xu, Y; Yuan, Z; Zhang, J; Zheng, J | 1 |
Inoue, Y; Kanamori, K; Matsui, M; Nishiyama, N; Nomoto, T; Suzuki, M; Takemoto, H; Tomoda, K; Yao, Y | 1 |
Aoki, M; Harada, T; Hirose, K; Ichise, K; Kato, T; Sato, M; Takai, Y; Takeda, K; Wada, Y | 1 |
Fukunaga, H; Matsuya, Y; Omura, M; Tokuuye, K | 1 |
Fukuda, H; Hiratsuka, J | 1 |
Jevremovic, T; Moffitt, G; Stewart, RD; Streitmatter, SW | 1 |
Birault, A; Chinnathambi, S; Doan, TL; Komatsu, A; Laird, M; Mai, NXD; Matsumoto, K; Morrison, K; Raitano, A; Suzuki, M; Takata, T; Tamanoi, F | 1 |
Ding, Q; Han, X; Li, S; Liu, Z; Qi, H; Qiao, X; Song, Y; Zhong, Y; Zhou, G | 1 |
Choi, JS; Lee, S; Ryu, KS; Song, SJ | 1 |
Aubatin, A; Castellano, F; Decrouy, X; Donnadieu, E; Molinier-Frenkel, V; Sako, N | 1 |
Castellano, F; Molinier-Frenkel, V | 1 |
Cortez-Maya, S; Hernández-Ortega, S; Martínez-García, M; Martínez-Klimov, ME; Martínez-Klimova, E; Pedro-Hernández, LD; Ramírez-Ápan, T; Vargas-Medina, AC | 1 |
Buuh, ZY; Cai, W; Du, J; Jiang, D; Kang, L; Lyu, Z; McGuth, JC; Wang, RE; Wissler, HL | 1 |
Brustad, EM; Chilkoti, A; Costa, SA; Dzuricky, MJ; Isaacs, FJ; Mozhdehi, D | 1 |
Arano, Y; Hanaoka, H; Higuchi, T; Ishioka, NS; Ohshima, Y; Suzuki, H; Tsushima, Y; Yamaguchi, A | 1 |
Gao, YF; Liu, J; Qi, YM; Shi, RR; Zhai, MX; Zhai, WJ; Zou, Z | 1 |
Goto, K; Hamura, K; Kwon, O; Lee, C; Lu, J; Tamanoi, F; Yoshimura, K | 1 |
Alvfors, C; Berglund, Å; Gullbo, J; Hagberg, H; Harmenberg, J; Jerling, M; Lewensohn, R; Lisyanskaya, A; Nordström, E; Nygren, P; Orlov, S; Ringbom, M; Söderlind, K; Spira, J; Tholander, B; Ullén, A | 1 |
Yoshimoto, M | 1 |
Li, W; Liu, Q; Liu, Y; Ma, E; Sheng, L; Shi, J; Sun, H; Yuan, L; Zhang, C; Zou, C | 1 |
Xiao, YX; Yang, WX | 1 |
Ali, MR; El-Sayed, MA; Fernández, FM; Han, T; Tang, Y; Wu, R; Wu, Y; Xiao, H; Zang, X | 1 |
Nakamura, H | 1 |
Albritton, JR; Auterinen, I; Binns, PJ; Harling, OK; Kiger, WS; Marek, M; Moss, RL; Nievaart, VA; Rezaei, A; Riley, KJ; Savolainen, S; Seppälä, T; Sköld, K; Viererbl, L | 1 |
Ageno, W; Appio, L; Brivio, L; Campiotti, L; Crowther, M; Dentali, F; Grandi, AM; Squizzato, A | 1 |
Collette, L; Moss, R; Sauerwein, WA; Wittig, A | 1 |
Altieri, S; Cionini, L; Menichetti, L; Minn, H; Salvadori, PA; Sauerwein, WA; Solin, O | 1 |
Arnopolskaya, AM; Khokhlov, VF; Kozlovskaya, NG; Kulakov, VN; Mitin, VN; Portnov, AA; Sheino, IN; Zaitsev, KN | 1 |
Aburai, K; Kawatobi, S; Matsumura, A; Nakai, K; Okuno, H; Shirakawa, M; Tsurubuchi, T; Yamamoto, Y; Yamamto, T; Yokoyama, Y | 1 |
Fang, H; Li, M; Li, Q; Wang, X; Xu, W; Yuan, Y; Zhang, L; Zhang, X; Zhu, H | 1 |
Fang, Q; Feng, C; Gu, G; Hou, J; Li, Z; Liu, P; Shen, J; Shi, Y; Wang, H; Wang, P; Xu, F; Yin, Z | 1 |
Cho, SH; Duin, EC; Hong, JW; Jambovane, S; Kim, SK; Yun, JY | 1 |
Guan, W; Hu, Z; Huang, Y; Sun, S; Yao, Y; Zhang, C | 1 |
Barsoum, J; Borella, C; Foley, KP; Jiang, J; Korbut, T; Li, H; Sang, J; Sonderfan, AJ; Wu, Y; Ye, J; Zhang, M; Zhang, X; Zhou, D | 1 |
Fujiwara, K; Kinashi, Y; Kurihara, K; Ono, K; Sakurai, Y; Takahashi, S; Takahashi, T; Tanaka, H; Yashima, H | 1 |
Alam, S; Chauhan, VS; Kaul, A; Kumar, S; Kundu, GC; Mishra, AK; Panda, JJ | 1 |
Augustin, HG | 1 |
KHOKHLOV, AS; LARIONOV, LF; NOVIKOVA, MA; SHKODINSKAJA, EN; TROOSHEIKINA, VI; VASINA, OS | 1 |
BALTUS, E; LEDOUX, L; VANDERHAEGHE, F | 1 |
DI PIETRO, S | 1 |
CHEBOTAREVA, LI | 1 |
SELIGER, H | 1 |
GIGANTE, D | 1 |
ESTEVEZ, RA; TRIMBOLI DE ESTEVEZ, O | 1 |
ECKHARDT, A; SELLEI, C | 1 |
TRUSHEIKINA, VI | 2 |
CREECH, O; KREMENTZ, ET; RYAN, RF | 1 |
BAKER, BR; BREENBERG, J; GREENE, MO | 1 |
P'AN, CT | 1 |
CASTELLANO, M; CATTANEO, C | 1 |
DAVYDOVA, SIa; SAPOZHNIKOVA, MB | 1 |
DIDDLE, AW; JENKINS, HH; WATTS, G; WATTS, J | 1 |
SMIRNOVA, EV | 1 |
CHIRIGOS, MA; FANNING, GR; GUROFF, G | 1 |
PAN, TT | 1 |
CHEN, JT; HSU, B; KAO, YS; PAN, PC | 1 |
CHEN, JT; HSU, B; JEN, YF; KAO, YS; WU, TC | 1 |
SULLIVAN, MP; SUTOW, WW; TAYLOR, G | 1 |
NIELSEN, G | 1 |
CHANG, HY; CHI, HC; FAN, LL; HAN, J; HO, S; LEI, HP; LI, KT; LIU, KT; WANG, CK | 1 |
GENTY, N; MELONI, GA; VENDRELY, R | 1 |
CHO, YS; MORRIS, HP; PITOT, HC | 1 |
BELLELLI, L; BONACCISEZZI, ML | 1 |
DOGLIOTTI, GC | 1 |
CHRISTENSEN, HN | 1 |
CHANG, CN; CHEN, PZ; CHOW, HL; YIH, YF; YUEN, CY | 1 |
AMOS, H; ASKONAS, B; SOEIRO, R | 1 |
LORINCZ, AB; RYAN, WL | 1 |
KHROMOV, BM; KIREEVA, OV | 1 |
CLARK, RL; SMITH, JL; STEHLIN, JS | 1 |
BAKER, BR; GOODMAN, L; LEE, WW; MARTINEZ, AP; SCHELSTRAETE, MG; TONG, GL; WEINSTEIN, B | 1 |
LEVINE, RJ; LOVENBERG, W; SJOERDSMA, A | 1 |
ALLAN, JD; IRELAND, JT; MILNER, J; MOSS, AD | 1 |
KLATT, O; MILNER, AN; STEHLIN, JS; YOUNG, SE | 1 |
BADEN, HP; PEARLMAN, C | 1 |
FOX, WW; HAWKINS, RA; SCANLON, EF; SMITH, WS | 1 |
BUTEL, JS; FELDMAN, LA; KITAHARA, T; MELNICK, JL; RAPP, F | 1 |
DAO, TL; GRINBERG, R; NEMOTO, T | 1 |
KHOKHLOV, AS; LARIONOV, LF; NOVIKOVA, MA; SKHODINSKAIA, EN; TRUSHEIKINA, VL; VASINA, OS | 1 |
LARIONOV, LF; PEREVODCHIKOVA, NI | 1 |
PUKHAL'SKAIA, ECh | 1 |
HRUBAN, Z; SLESERS, A; WISSLER, RW | 1 |
RILEY, V | 1 |
Didziapetriene, J; Kadziauskas, J; Stanciūte, D | 1 |
Asano, T; Hattori, Y; Kirihata, M; Kondoh, H; Niki, Y; Wakamiya, T; Yamaguchi, Y | 1 |
Arakawa, H; Futamura, M; Kamino, H; Nakamura, Y; Yoshida, K | 1 |
Cornelissen, B; de Spiegeleer, B; Kersemans, K; Kersemans, V; Mertens, J; Slegers, G; Staelens, L | 1 |
Deisenroth, C; Jin, A; Lindström, MS; White Wolf, G; Zhang, Y | 1 |
Bidart, JM; Boige, V; Delaloge, S; Le Couedic, JP; Motté, N; Pautier, P; Saulnier, P; Soria, JC; Vainchenker, W; Villeval, JL | 1 |
Herz, F; Leahy, EM; Singer, RM | 1 |
Lin, JK; Wang, CH | 1 |
Dhondt, JL; Farriaux, JP | 1 |
Fishman, WH; Millán, JL; Ruoslahti, E; Stigbrand, T | 1 |
Barre, M; Bernard, L; Deumier, R; Donzelle, G; Lacome, M; Lanier, M; Mourtada, MB | 1 |
Judd, KP; Reif, AE; Southwick, PL | 1 |
Brown, PD | 1 |
Allen, BJ | 1 |
Chauvel, P; Pignol, JP | 1 |
Blumenkopf, TA; Cory, M; Elwell, L; Laethem, RM; Moxham, CP; Ray, PH; Smith, GK; Walton, LM | 1 |
Barter, J; Cole, A; Dickson, R; Hawkins, MJ; Low, J; Marshall, J; McCann, P; Moore, J; Ness, E; Sale, M; Wojtowicz-Praga, S | 1 |
Bartlett, K; Brock, C; Craft, AW; Daley, SE; Halliday, D; Hetherington, C; Kernahan, J; Pearson, AD; Price, L; Wyllie, RA | 1 |
Kuwano, M; Ono, M | 2 |
Brown, PD; Talbot, DC | 1 |
Carlsson, J; Gedda, L; Ghaneolhosseini, H; Hartman, T; Malmquist, J; Naeslund, C; Olsson, P; Sjöberg, S; Tjarks, W | 1 |
Dickson, RB; Hawkins, MJ; Wojtowicz-Praga, SM | 1 |
Imashuku, S | 1 |
Denis, LJ; Verweij, J | 1 |
Beattie, GJ; Smyth, JF | 1 |
Baramova, E; Foidart, JM; Frankenne, F; Maquoi, E; Munaut, C; Murphy, G; Noël, A; Remacle, A; Sounni, NE | 1 |
Broxterman, HJ; Gebbink, MF; Hoekman, K; Jorna, AS; Pinedo, HM; Verheul, HM | 1 |
Eckhardt, SG; Hidalgo, M | 1 |
Itoh, T; Itohara, S; Lannoy, K; Libert, C; Shapiro, SD; Vandekerckhove, J; Wielockx, B | 1 |
Kinashi, Y; Kobayashi, T; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Takagaki, M | 1 |
Kolár, J; Stĕpán, J; Volek, V | 1 |
Kubíková-Kourilová, A | 1 |
Matsumoto, M | 1 |
Wheatley, DN | 1 |
Ren, YF; Zheng, YY | 1 |
Kokolis, N; Ziegler, I | 1 |
Blokhin, NN | 1 |
Kitamura, M; Nakayama, T | 1 |
Arima, T; Fujii, S; Niinobe, M; Okuda, H; Tamura, Y | 1 |
Brennan, MF; Burt, ME; Gonenne, A; Heslin, MJ; Newman, E; Pearlstone, DB; Wolf, RF | 1 |
Bennett, BD; Gay, I; Morrison, GH; Zha, X | 1 |
Matsumoto, H; Mori, S | 1 |
Barth, RF; Fairchild, RG; Soloway, AH | 1 |
Duch, DS; Nichol, CA; Smith, GK | 1 |
Carter, JC; Jozwiak, EL; Mallinger, AG | 1 |
Folkers, K | 1 |
Presant, CA; Serpick, AA; Wiernik, PH | 1 |
Bodansky, O; Fleisher, M; Schwartz, MK | 1 |
Gingold, N; Pittermann, E; Stacher, A | 1 |
Galt, RM; Knock, FE; Oester, YT; Sylvester, R | 1 |
Stiller, KJ | 1 |
Hricko, AM | 1 |
Burdette, WJ | 1 |
Craddock, VM | 1 |
Demetriou, J; Nadler, S; Pileggi, VJ; Winkelman, J | 1 |
Hahn, K; Jesdinsky, HJ; Ladner, HA | 1 |
Kellen, JA; Lustig, V | 1 |
Hultin, T | 1 |
Stolbach, LL | 1 |
Glick, D; Hosoda, S | 1 |
Timperley, WR; Warnes, TW | 1 |
Fishman, WH; Green, S | 1 |
Bodnaryk, RP | 1 |
Montenero, P; Monti, A | 1 |
Kao, YS; Lee, T; Pan, PC; Yao, HY | 1 |
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
25 review(s) available for phenylalanine and Neoplasms
Article | Year |
---|---|
Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
Topics: Antineoplastic Agents; Cytotoxins; Drug Carriers; Drug Delivery Systems; Drug Design; Humans; Immunoconjugates; Melphalan; Neoplasms; Peptides; Pharmaceutical Preparations; Phenylalanine; Radiotherapy; Somatostatin | 2021 |
Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with
Topics: Animals; Borohydrides; Boron Neutron Capture Therapy; Humans; Neoplasms; Phenylalanine; Relative Biological Effectiveness; Sulfhydryl Compounds; Tissue Distribution | 2021 |
Pharmacokinetics of
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Glioblastoma; Humans; Isotopes; Melanoma; Neoplasms; Phenylalanine; Positron-Emission Tomography | 2020 |
An Overview of l-Amino Acid Oxidase Functions from Bacteria to Mammals: Focus on the Immunoregulatory Phenylalanine Oxidase IL4I1.
Topics: Adaptive Immunity; Animals; B-Lymphocytes; Bacteria; Cell Differentiation; Cell Proliferation; Gene Expression Regulation; Germinal Center; Humans; L-Amino Acid Oxidase; Macrophages; Mice; Neoplasms; Oxidation-Reduction; Phenylalanine; T-Lymphocytes, Regulatory; Th17 Cells | 2017 |
[Current Status and Prospects on PET Radiopharmaceuticals for Radiotherapy].
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Coordination Complexes; Fluorine Radioisotopes; Humans; Hypoxia; Misonidazole; Neoplasms; Nitroimidazoles; Organometallic Compounds; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones | 2015 |
KIFC1: a promising chemotherapy target for cancer treatment?
Topics: Alanine; Antineoplastic Agents; Centrosome; DNA; Female; Humans; Kinesins; Mitosis; Molecular Targeted Therapy; Neoplasms; Oocytes; ortho-Aminobenzoates; Phenanthrenes; Phenylalanine; Pregnancy; Protein Transport; Pyridines; Signal Transduction; Spermatogenesis | 2016 |
[Boron delivery system for neutron capture therapy of cancer].
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Drug Delivery Systems; Humans; Liposomes; Neoplasms; Phenylalanine; Positron-Emission Tomography | 2008 |
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.
Topics: Algorithms; Amino Acid Substitution; Biomarkers, Tumor; Case-Control Studies; Early Detection of Cancer; Female; Gene Frequency; Humans; Janus Kinase 2; Male; Myeloproliferative Disorders; Neoplasms; Phenylalanine; Philadelphia Chromosome; Point Mutation; Valine; Venous Thromboembolism | 2009 |
[Angiogenesis research--quo vadis?].
Topics: Adult; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Bevacizumab; Cell Communication; Drug Evaluation, Preclinical; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Ephrins; Forecasting; Growth Substances; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Lymphokines; Metalloendopeptidases; Mice; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Phenylalanine; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Research; Signal Transduction; Thalidomide; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
[REGIONAL PERFUSION IN CLINICAL PRACTICE; (REVIEW OF LITERATURE)].
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Mechlorethamine; Neoplasms; Perfusion; Phenylalanine | 1963 |
[Expression of matrix metalloproteinases in patients with malignant tumors].
Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Clinical Trials as Topic; Diphosphonates; Disease Progression; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasms; Organic Chemicals; Phenylalanine; Phenylbutyrates; Prognosis; Protease Inhibitors; Thiophenes; Time Factors; Tissue Inhibitor of Metalloproteinases | 2004 |
[Tetrahydroblopterin. Metabolism and metabolic role of unconjugated pteridines (author's transl)].
Topics: Animals; Biological Transport; Biopterins; Cattle; Humans; Mice; Mixed Function Oxygenases; Neoplasms; Neurotic Disorders; Oxidation-Reduction; Phenylalanine; Phenylketonurias; Pteridines; Rats | 1980 |
[Neutron capturing irradiation: principle, current results and perspectives].
Topics: Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cell Survival; Drug Carriers; Humans; Linear Energy Transfer; Neoplasms; Nuclear Reactors; Particle Accelerators; Phenylalanine; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sulfhydryl Compounds | 1995 |
[Development of anti tumor agents targeting angiogenesis].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclohexanes; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hydroxamic Acids; Interferon-alpha; Interleukin-12; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phenylalanine; Platelet Factor 4; Polysaccharides, Bacterial; Sesquiterpenes; Thalidomide; Thiophenes; Triazines; Triazoles; Tumor Cells, Cultured | 1997 |
Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Ascites; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Extracellular Matrix; Female; Humans; Male; Metalloendopeptidases; Mice; Middle Aged; Neoplasms; Phenylalanine; Pleural Effusion, Malignant; Protease Inhibitors; Rats; Thiophenes | 1996 |
Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.
Topics: Amino Acids; Boron Compounds; Boron Neutron Capture Therapy; DNA; Humans; Intercalating Agents; Molecular Structure; Neoplasms; Phenylalanine; Structure-Activity Relationship | 1997 |
Matrix metalloproteinase inhibitors.
Topics: Antineoplastic Agents; Cell Division; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Down-Regulation; Drugs, Investigational; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Hydroxamic Acids; Metalloendopeptidases; Molecular Weight; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Protein Kinase C; Proteins; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Tissue Inhibitor of Metalloproteinases | 1997 |
Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment.
Topics: Adult; Afibrinogenemia; Aged; Anticonvulsants; Autoimmune Diseases; Biomarkers; Child; Cytokines; Diagnosis, Differential; Ferritins; Histiocytosis, Non-Langerhans-Cell; Humans; Hypertriglyceridemia; Infections; Killer Cells, Natural; Lymphoma; Neoplasms; Phenylalanine | 1997 |
Matrix metalloproteinase inhibitors: present achievements and future prospects.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Enzyme Inhibitors; Extracellular Matrix; Humans; Hydroxamic Acids; Metalloendopeptidases; Neoplasm Metastasis; Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1997 |
[Neovascularization and tumor development].
Topics: Angiostatins; Antibiotics, Antineoplastic; Antineoplastic Agents; Collagen; Cyclohexanes; Endostatins; Humans; Hydroxamic Acids; Interferons; Interleukin-12; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thalidomide; Thiophenes | 1998 |
Development of matrix metalloproteinase inhibitors in cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biphenyl Compounds; Clinical Trials as Topic; Drugs, Investigational; Enzyme Inhibitors; Humans; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Neoplasms; Organic Chemicals; Phenylalanine; Phenylbutyrates; Protease Inhibitors; Pyrazines; Sulfonamides; Tetracycline; Tetracyclines; Thiophenes | 2001 |
Biological and biochemical effects of phenylalanine analogs.
Topics: Aging; Animals; Cell Division; Enzyme Induction; Enzyme Repression; Flagella; Mutation; Neoplasms; Phenylalanine; Protein Biosynthesis; RNA; Transfer RNA Aminoacylation; Viruses | 1978 |
Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.
Topics: Alcohol Oxidoreductases; Animals; Biopterins; Body Fluids; Coenzymes; GTP Cyclohydrolase; Humans; Immune System Diseases; Mental Disorders; Metalloproteins; Molybdenum; Molybdenum Cofactors; Neoplasms; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines; Pterins; Tetrahydrofolate Dehydrogenase; Tissue Distribution; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1985 |
Current progress in the management of cancer. A collective review.
Topics: Adenocarcinoma; Angiography; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Chemotherapy, Cancer, Regional Perfusion; DNA, Neoplasm; Female; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Lymphography; Lymphoma, Non-Hodgkin; Male; Mammography; Melanoma; Mustard Compounds; Neoplasms; Phenylalanine; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Selenium; Skin Neoplasms; Thermography; Time Factors | 1969 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
5 trial(s) available for phenylalanine and Neoplasms
Article | Year |
---|---|
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies.
Topics: Adult; Aged; Aged, 80 and over; Alkylation; Antineoplastic Agents, Alkylating; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Male; Melphalan; Middle Aged; Neoplasms; Peptide Hydrolases; Phenylalanine; Prospective Studies | 2015 |
Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
Topics: Adenocarcinoma; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Colorectal Neoplasms; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Male; Neoplasms; Phenylalanine; Prospective Studies; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Thyroid Neoplasms; Tissue Distribution | 2009 |
Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Agents; Collagenases; Drug Administration Schedule; Female; Gelatinases; Humans; Injections, Intraperitoneal; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Middle Aged; Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1996 |
Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Dose-Response Relationship, Drug; Female; Humans; Male; Metalloendopeptidases; Middle Aged; Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1998 |
Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients.
Topics: Amino Acids; Blood Glucose; Creatinine; Female; Growth Hormone; Hematocrit; Humans; Insulin; Leucine; Male; Middle Aged; Muscle Proteins; Neoplasms; Phenylalanine; Recombinant Proteins | 1992 |
134 other study(ies) available for phenylalanine and Neoplasms
Article | Year |
---|---|
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines.
Topics: Amines; Amino Acids; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Conserved Sequence; Enzyme Activation; Humans; Isoenzymes; Kinetics; Molecular Sequence Data; Molecular Structure; Neoplasms; Sequence Alignment; Structure-Activity Relationship | 2008 |
Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.
Topics: Alkaline Phosphatase; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Neoplasms; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazoles; Pyrophosphatases; Structure-Activity Relationship | 2018 |
l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.
Topics: Antineoplastic Agents; Brain Diseases; Click Chemistry; Dose-Response Relationship, Drug; Histidine; Humans; Large Neutral Amino Acid-Transporter 1; Molecular Structure; Neoplasms; Prodrugs; Structure-Activity Relationship; Triazoles; Tryptophan | 2019 |
Tryptophan depletion results in tryptophan-to-phenylalanine substitutants.
Topics: Codon; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Neoplasms; Phenylalanine; T-Lymphocytes; Tryptophan; Tryptophan Oxygenase; Tryptophan-tRNA Ligase | 2022 |
Heterochiral dipeptide d-phenylalanyl- l-phenylalanine (H-
Topics: Animals; Cell Line; Cell Line, Tumor; Dipeptides; Mice; Neoplasms; Phenylalanine; Tumor Suppressor Protein p53 | 2022 |
Adsorption of folic acid molecule on diphenylalanine peptide nanohole as a drug delivery in cancer treatment: a molecular dynamics simulation study.
Topics: Adsorption; Folic Acid; Humans; Hydrogen Bonding; Molecular Dynamics Simulation; Neoplasms; Peptides; Phenylalanine; Water | 2023 |
Equilibria in the aqueous system of cobalt(II) based on 2-picolinehydroxamic acid and N-(2-hydroxybenzyl)phenylalanine and its ability to inhibit the propagation of cancer cells.
Topics: Animals; Cobalt; Coordination Complexes; Copper; DNA; Humans; Ligands; Mice; Neoplasms; Phenylalanine; Schiff Bases | 2023 |
Assessing the effectiveness of fluorinated and α-methylated 3-boronophenylalanine for improved tumor-specific boron delivery in boron neutron capture therapy.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Humans; Neoplasms; Phenylalanine; Tissue Distribution; Water | 2024 |
Application of Nitroimidazole-Carbobane-Modified Phenylalanine Derivatives as Dual-Target Boron Carriers in Boron Neutron Capture Therapy.
Topics: Animals; Boranes; Boron Compounds; Boron Neutron Capture Therapy; Cell Hypoxia; Cell Line, Tumor; Humans; Mice; Nanoparticles; Neoplasms; Nitroimidazoles; Phenylalanine; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |
Poly(vinyl alcohol) boosting therapeutic potential of
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Energy Metabolism; Humans; Mass Spectrometry; Mice; Neoplasms; Phenylalanine; Polyvinyl Alcohol; Radiation-Sensitizing Agents; Signal Transduction; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |
YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells.
Topics: Antineoplastic Agents; Boron Neutron Capture Therapy; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Deferoxamine; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Large Neutral Amino Acid-Transporter 1; MCF-7 Cells; Neoplasms; Neutrons; Oxygen; Phenylalanine; Radiation-Sensitizing Agents; RNA, Small Interfering | 2020 |
Implications of radiation microdosimetry for accelerator-based boron neutron capture therapy: a radiobiological perspective.
Topics: Boranes; Boron Compounds; Boron Neutron Capture Therapy; Fluorodeoxyglucose F18; Humans; Monte Carlo Method; Neoplasms; Phenylalanine; Radiobiology; Relative Biological Effectiveness | 2020 |
Mechanistic Modeling of the Relative Biological Effectiveness of Boron Neutron Capture Therapy.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Humans; Linear Energy Transfer; Monte Carlo Method; Neoplasms; Phenylalanine; Radiometry; Radiotherapy, Conformal; Receptor, ErbB-2; Relative Biological Effectiveness; Trastuzumab | 2020 |
Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy.
Topics: Antineoplastic Agents; Apoptosis; Boron Compounds; Cell Proliferation; Humans; Metal Nanoparticles; Neoplasms; Organosilicon Compounds; Phenylalanine; Tumor Cells, Cultured | 2021 |
Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Aspartic Acid; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; HeLa Cells; Humans; Molecular Docking Simulation; Neoplasms; Phenylalanine; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2017 |
Amphiphilic Peptide Nanorods Based on Oligo-Phenylalanine as a Biocompatible Drug Carrier.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Curcumin; Drug Carriers; HeLa Cells; Hemolysis; Humans; Nanotubes; Neoplasms; Oligopeptides; Phenylalanine; Surface-Active Agents; Zebrafish | 2017 |
IL4-induced gene 1 is secreted at the immune synapse and modulates TCR activation independently of its enzymatic activity.
Topics: CD28 Antigens; Cell Communication; Cell Differentiation; Cell Proliferation; Humans; Immunosuppression Therapy; Interleukin-4; L-Amino Acid Oxidase; Lymphocyte Activation; Macrophages; Neoplasms; Neutrophils; Phenylalanine; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; Tumor Escape; ZAP-70 Protein-Tyrosine Kinase | 2018 |
Anticancer Activity of Resorcinarene-PAMAM-Dendrimer Conjugates of Flutamide.
Topics: Antineoplastic Agents; Apoptosis; Calixarenes; Cell Line, Tumor; Cell Proliferation; Dendrimers; Drug Carriers; Flutamide; Humans; Models, Molecular; Neoplasms; Phenylalanine | 2018 |
A Switchable Site-Specific Antibody Conjugate.
Topics: Animals; Antibodies; Binding Sites; Codon, Terminator; Genes, Switch; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Immunologic Factors; Neoplasms; Peptides; Phenylalanine | 2018 |
Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Elastin; Humans; Ligands; Micelles; Nanoparticles; Neoplasms; Peptides; Phenylalanine | 2019 |
Novel
Topics: Animals; Cell Line, Tumor; Diagnosis, Differential; Fluorine Radioisotopes; Humans; Injections, Intravenous; Large Neutral Amino Acid-Transporter 1; Male; Mice; Neoplasms; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |
The immunogenicity of a novel cytotoxic T lymphocyte epitope from tumor antigen PL2L60 could be enhanced by 4-chlorophenylalanine substitution at position 1.
Topics: Alternative Splicing; Amino Acid Sequence; Amino Acid Substitution; Animals; Antigens, Neoplasm; Argonaute Proteins; Blotting, Western; Cell Line; Cytotoxicity, Immunologic; Epitopes, T-Lymphocyte; Gene Expression Regulation, Neoplastic; HLA-A2 Antigen; HT29 Cells; Humans; Interferon-gamma; MCF-7 Cells; Mice; Mice, Transgenic; Neoplasms; Peptides; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes, Cytotoxic | 2013 |
Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.
Topics: Alkyl and Aryl Transferases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Enzyme Inhibitors; Humans; Liposomes; Neoplasms; Phenylalanine; Protein Prenylation; Sulfonamides | 2015 |
Design, synthesis and biological evaluation of novel asperphenamate derivatives.
Topics: Antineoplastic Agents; Autophagy; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Neoplasms; Phenylalanine; Structure-Activity Relationship | 2016 |
Simultaneous Time-Dependent Surface-Enhanced Raman Spectroscopy, Metabolomics, and Proteomics Reveal Cancer Cell Death Mechanisms Associated with Gold Nanorod Photothermal Therapy.
Topics: Cell Death; Cell Line, Tumor; Gold; Humans; Metabolomics; Nanotubes; Neoplasms; Particle Size; Phenylalanine; Phototherapy; Proteomics; Spectrum Analysis, Raman; Surface Properties; Time Factors | 2016 |
An international dosimetry exchange for BNCT part II: computational dosimetry normalizations.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Clinical Trials as Topic; Humans; Isotopes; Neoplasms; Phantoms, Imaging; Phenylalanine; Radiation-Sensitizing Agents; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Software; Treatment Outcome | 2008 |
Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Fluorine Radioisotopes; Humans; Isotopes; Lymphatic Metastasis; Melanoma; Models, Biological; Neoplasms; Phenylalanine; Positron-Emission Tomography; Prognosis; Radiation-Sensitizing Agents; Tomography, X-Ray Computed | 2009 |
Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.
Topics: Animals; Bone Neoplasms; Boron Compounds; Boron Neutron Capture Therapy; Combined Modality Therapy; Dog Diseases; Dogs; Gadolinium; Humans; Melanoma; Mouth Neoplasms; Neoplasms; Neutron Capture Therapy; Osteosarcoma; Phenylalanine | 2009 |
Synthesis and evaluation of a novel liposome containing BPA-peptide conjugate for BNCT.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Drug Delivery Systems; Humans; Isotopes; Lipopeptides; Liposomes; Membrane Potentials; Neoplasms; Particle Size; Phenylalanine; Radiation-Sensitizing Agents; tat Gene Products, Human Immunodeficiency Virus | 2009 |
Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Topics: Animals; Antineoplastic Agents; CD13 Antigens; Cell Proliferation; HL-60 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Phenylalanine; Piperidones; Protease Inhibitors; Structure-Activity Relationship; Swine | 2010 |
Structure-based optimization of click-based histone deacetylase inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Click Chemistry; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxamic Acids; Models, Molecular; Neoplasms; Phenylalanine; Protein Binding; Protein Structure, Secondary; Structure-Activity Relationship; Triazoles; Vorinostat | 2011 |
Log-scale dose response of inhibitors on a chip.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Kinetics; Lab-On-A-Chip Devices; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Microchip Analytical Procedures; Neoplasms; Phenylalanine; Sensitivity and Specificity; Spectrometry, Fluorescence; Thiophenes | 2011 |
Photodynamic anticancer activities of water-soluble C(60) derivatives and their biological consequences in a HeLa cell line.
Topics: Antineoplastic Agents; Apoptosis; Arginine; Caspase 3; Catalase; Cell Survival; Folic Acid; Fullerenes; Glutathione Peroxidase; HeLa Cells; Humans; Light; Malondialdehyde; Membrane Potential, Mitochondrial; Neoplasms; Phenylalanine; Photochemotherapy; Reactive Oxygen Species; Superoxide Dismutase; Water | 2012 |
The vascular disrupting agent STA-9584 exhibits potent antitumor activity by selectively targeting microvasculature at both the center and periphery of tumors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Survival; Dogs; Female; Heart; Hemodynamics; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Microcirculation; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Rabbits; Regional Blood Flow; Tubulin Modulators; Xenograft Model Antitumor Assays | 2012 |
Induced radioactivity in the blood of cancer patients following Boron Neutron Capture Therapy.
Topics: Blood; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain; Deuterium Oxide; Equipment Design; Gamma Rays; Germanium; Humans; Lung; Neck; Neoplasms; Neutrons; Phenylalanine; Radiometry; Radiotherapy Dosage; Regression Analysis; Skin; Sodium Isotopes; Sulfhydryl Compounds | 2013 |
Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug delivery.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Dipeptides; Doxorubicin; Drug Delivery Systems; Female; Folic Acid; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Phenylalanine | 2013 |
Studies on the anti-tumour activity of p-di-(2-chloroethyl) aminophenylalanine (sarcolysine).
Topics: Melphalan; Neoplasms; Phenylalanine; Sarcoma; Sarcoma, Experimental | 1955 |
[Effect of ribonuclease on the incorporation of adenine and phenylalanine in ascites cells in vitro].
Topics: Adenine; Ascites; Biochemical Phenomena; DNA; Endonucleases; In Vitro Techniques; Neoplasms; Phenylalanine; Ribonucleases; RNA | 1956 |
[Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
Topics: Animals; Antineoplastic Agents; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine; Sarcoma | 1956 |
[Experience in treating seminoma of the testes and its metastases with sarcolysin].
Topics: Dysgerminoma; Female; Humans; Male; Melphalan; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phenylalanine; Seminoma; Testicular Neoplasms; Testis | 1956 |
[A new chemotherapeutic agent for control of malignant tumors: p-di-(-2-chloroethyl)-aminophenylanine (sarcolysine)].
Topics: Antineoplastic Agents; Humans; Melphalan; Neoplasms; Phenylalanine | 1956 |
[Clinical observations on the use of p-bis-(beta-chloroethyl) aminophenylalanine in the treatment of reticulosarcomatosis and lymphosarcomatosis].
Topics: Antineoplastic Agents; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Phenylalanine; Sarcoma | 1956 |
[Treatment of neoplasms with a phenylalanine derivative of nitrogen mustard].
Topics: Humans; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine | 1958 |
[Clinical trials of mechlorethamine-N-oxide in therapy of tumors].
Topics: Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Oxides; Phenylalanine | 1958 |
[Anti-tumor activity of optic isomers of sarcolysin].
Topics: Isomerism; Mechlorethamine; Melphalan; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine | 1958 |
Treatment of melanoma by isolation-perfusion technique.
Topics: Humans; Leg; Mechlorethamine; Melanoma; Neoplasms; Nitrogen Mustard Compounds; Perfusion; Phenylalanine | 1959 |
Meta-bis-(2-chloroethylamino)-dL-phenylalanine in the treatment of mouse tumors.
Topics: Animals; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine | 1960 |
[On inclusion of C14-labeled phenylalanine into the proteins of sarcoma 45 and the normal organs of rats].
Topics: Animals; Biochemical Phenomena; Neoplasms; Phenylalanine; Proteins; Rats; Sarcoma | 1961 |
[Repeated remissions in a case of beta-plasmocytoma; variations in the blood protein picture during p-bis(2-chloroethyl)-aminophenylalanine therapy].
Topics: Blood Proteins; Humans; Multiple Myeloma; Neoplasms; Phenylalanine; Plasma Cells; Plasmacytoma | 1959 |
[The effect of sarcolysin and dopan on the biosynthesis of pyrimidines of nucleic acid in transplanted tumors and tissues of the recipient organism].
Topics: Mechlorethamine; Melphalan; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nucleic Acids; Phenylalanine; Pyrimidines; Uracil Mustard | 1960 |
Nitrogen and phenylalanine mustard. Use in women with intrauterine cancer.
Topics: Female; Humans; Mechlorethamine; Melphalan; Neoplasms; Nitrogen; Nitrogen Mustard Compounds; Phenylalanine; Uterine Neoplasms | 1962 |
[Phenylalanine hydroxylase activity in hepatomas and livers of normal and tumor-bearing animals].
Topics: Animals; Carcinoma, Hepatocellular; Enzymes; Liver; Liver Neoplasms; Neoplasms; Phenylalanine; Phenylalanine Hydroxylase; Tyrosine | 1961 |
Effects of amino acids, analogs, and certain other agents in relation to tyrosine transport in sarcoma 37 ascites cells.
Topics: Amino Acids; Animals; Ascites; Azides; Cyanides; Iodoacetates; Malonates; Neoplasms; Nitrophenols; Organic Chemicals; Phenylalanine; Sarcoma; Sarcoma 37; Sarcoma, Experimental; Tyrosine | 1962 |
The incorporation of phenylalanine-C14 into the proteins of sarcoma 45 and of the normal organs of rats.
Topics: Animals; Biochemical Phenomena; Neoplasms; Phenylalanine; Proteins; Rats; Sarcoma | 1962 |
Tumour chemotherapy. V. Synthesis of some o-substituted-p-[bis-(2-chloroethylamino]-phenylalanine and test of antitumour action.
Topics: Antineoplastic Agents; Neoplasms; Phenylalanine | 1962 |
Tumor chemotherapy. VII. Synthesis of p-, m- and o-[bis-(2-chloroethyl)-aminoethyl]-phenylalanine dihydrochloride and their antitumour action.
Topics: Antineoplastic Agents; Neoplasms; Neoplasms, Experimental; Phenylalanine | 1962 |
L-PHENYLALANINE MUSTARD AS A TREATMENT FOR METASTATIC OSTEOGENIC SARCOMA IN CHILDREN.
Topics: Bone Marrow Diseases; Bone Neoplasms; Child; Humans; Lung Neoplasms; Mustard Plant; Neoplasm Metastasis; Neoplasms; Nitrogen Mustard Compounds; Osteosarcoma; Phenylalanine; Radiography, Thoracic; Sarcoma; Toxicology | 1963 |
[THE EFFECT OF P-FLUORPHENYLALANINE ON THE REPRODUCTION OF VACCINIA VIRUS IN HELA CELLS].
Topics: DNA; DNA, Viral; Electrons; HeLa Cells; Humans; Inclusion Bodies; Microscopy; Microscopy, Electron; Neoplasms; Phenylalanine; Tissue Culture Techniques; Vaccinia virus; Virus Cultivation | 1963 |
[STUDIES ON ANTITUMOR DRUGS. VIII. THE ANTITUMOR EFFECT OF THE ETHYL ESTER OF N-FORMYL-SARCOLYSIN- PHENYLALANINE ON EXPERIMENTAL TUMORS].
Topics: Animals; Antineoplastic Agents; Haplorhini; Mice; Neoplasms; Pharmacology; Phenylalanine; Research; Retinitis Pigmentosa; Sarcoma; Sarcoma, Yoshida | 1963 |
[CONTRIBUTION TO THE STUDY OF RIBONUCLEOPROTEINS OF NORMAL AND NEOPLASTIC TISSUES].
Topics: Alanine; Arginine; Aspartic Acid; Chemical Phenomena; Chemistry; Glutamates; Glycine; Isoleucine; Leucine; Liver; Lysine; Mice; Neoplasm Proteins; Neoplasms; Nucleoproteins; Phenylalanine; Rats; Research; Ribonucleoproteins; RNA; RNA, Neoplasm; Serine; Threonine; Tyrosine; Valine | 1963 |
METABOLIC ADAPTATIONS IN RAT HEPATOMAS. VI. SUBSTRATE-HORMONE RELATIONSHIPS IN TRYPTOPHAN PYRROLASE INDUCTION.
Topics: Adrenalectomy; Carbon Isotopes; Carcinoma, Hepatocellular; Cortisone; Hypophysectomy; Liver; Liver Neoplasms; Methionine; Neoplasms; Neoplasms, Experimental; Oxygenases; Phenylalanine; Portacaval Shunt, Surgical; Proteins; Rats; Research; RNA; RNA, Neoplasm; Tryptophan; Tryptophan Oxygenase | 1964 |
[INCORPORATION IN VITRO OF PHENYLALANINE-U-C-14 IN ASCITES CELLS OF I.R.E. RETICULOSARCOMA].
Topics: Animals; Ascites; Carbon Isotopes; In Vitro Techniques; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Phenylalanine; Sarcoma; Sarcoma, Experimental | 1963 |
[EARLY DIAGNOSIS AND MEDICAL THERAPY OF MALIGNANT TUMORS].
Topics: Antineoplastic Agents; Busulfan; Colchicine; Early Diagnosis; Hodgkin Disease; Mechlorethamine; Mercaptopurine; Neoplasms; Phenylalanine; Podophyllum; Triethylenemelamine; Vinblastine | 1963 |
A TRANSPORT SYSTEM SERVING FOR MONO- AND DIAMINO ACIDS.
Topics: Amino Acids; Aminobutyrates; Aminoisobutyric Acids; Arginine; Asparagine; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Glutamine; Glycine; Leucine; Lysine; Neoplasms; Ornithine; Phenylalanine; Proteins; Research | 1964 |
[CHEMOTHERAPY OF CANCER. V. SYNTHESIS OF SEVERAL PHENYLALANINES CONTAINING BIS-(2-CHLOROETHYL)AMINO GROUP].
Topics: Chemistry, Pharmaceutical; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine; Research | 1964 |
EVIDENCE FOR MESSENGER ACTIVITY OF ALIEN RIBONUCLEIC ACID IN CHICK CELLS.
Topics: Chick Embryo; Dactinomycin; Leucine; Metabolism; Neoplasms; Nucleotides; Pharmacology; Phenylalanine; Proteins; RNA; RNA, Bacterial; RNA, Messenger; RNA, Neoplasm | 1964 |
FREE AMINO ACIDS OF HUMAN BREAST CANCER.
Topics: Amino Acids; Asparagine; Aspartic Acid; Breast Neoplasms; Chromatography; Citrulline; Glutamates; Glutamine; Glycine; Humans; Isoleucine; Leucine; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Proline; Research; Serine; Threonine; Tyrosine | 1964 |
HISTOPATHOLOGICAL CHANGES IN MALIGNANT MELANOMA AND NORMAL TISSUES FOLLOWING REGIONAL PERFUSION WITH L-PHENYLALANINE MUSTARD (L-SARCOLYSIN).
Topics: Chemotherapy, Cancer, Regional Perfusion; Extracorporeal Circulation; Lymphatic Metastasis; Melanoma; Melphalan; Mice; Mustard Plant; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenylalanine; Research | 1964 |
SYNTHESIS OF N,N-BIS(2-CHLOROETHYL)-DL-PHENYLALANINE HYDROCHLORIDE.
Topics: Adenocarcinoma; Animals; Carcinoma; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Leukemia L1210; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Pharmacology; Phenylalanine; Research; Sarcoma 180 | 1963 |
HYDROXYLATION OF TRYPTOPHAN AND PHENYLALANINE IN NEOPLASTIC MAST CELLS OF THE MOUSE.
Topics: Animals; Hydroxylation; Indoles; Mast Cells; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Research; Tryptophan; Tyrosine | 1964 |
TREATMENT OF LEUKAEMIA BY AMINOACID IMBALANCE.
Topics: Amino Acids; Child; Diet; Diet Therapy; Dietary Proteins; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphocytes; Neoplasms; Phenylalanine; Tyrosine | 1965 |
THE BIOCHEMICAL MECHANISM OF ACTION OF L-PHENYLALANINE MUSTARD. I. DISTRIBUTION OF L-PHENYLALANINE MUSTARD-H3 IN TUMOR-BEARING RATS.
Topics: Animals; Bone Marrow; Carcinoma 256, Walker; Chromatography; DNA; Intestines; Kidney; Liver; Melphalan; Metabolism; Muscles; Mustard Plant; Neoplasms; Pharmacology; Phenylalanine; Plasma; Rats; Research; Spleen; Thymus Gland; Tritium; Tyrosine | 1965 |
STUDIES OF EPIDERMAL PROTEIN METABOLISM. 3. PROTEIN SYNTHESIS IN AN EPIDERMAL CARCINOMA IN VIVO AND IN VITRO.
Topics: Carbon Isotopes; Cricetinae; Histological Techniques; In Vitro Techniques; Leucine; Liver; Magnesium; Microsomes; Neoplasm Proteins; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenylalanine; Proteins; Research; Ribosomes; Skin Neoplasms; Uracil Nucleotides | 1965 |
FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT.
Topics: Humans; Melanoma; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Pathology; Phenylalanine; Transplantation, Homologous | 1965 |
DIFFERENTIAL EFFECTS OF INHIBITORS ON THE STEPS LEADING TO THE FORMATION OF SV40 TUMOR AND VIRUS ANTIGENS.
Topics: Animals; Antigens; Antigens, Viral; Antimetabolites; Chlorocebus aethiops; Complement Fixation Tests; Dactinomycin; DNA, Viral; Floxuridine; Fluorescence; Fluorescent Antibody Technique; Fluorouracil; Idoxuridine; Microscopy; Microscopy, Fluorescence; Mitomycin; Neoplasms; Nucleosides; Pharmacology; Phenylalanine; Puromycin; Research; Simian virus 40; Tissue Culture Techniques; Virus Cultivation | 1965 |
L-PHENYLALANINE MUSTARD (NSC-8806) IN UNCOMMON MALIGNANT DISEASE IN CHILDREN.
Topics: Child; Humans; Melphalan; Mustard Plant; Neoplasms; Phenylalanine; Toxicology | 1965 |
[ANTINEOPLASTIC ACTIVITY OF O-BIS(2-CHLOROETHYL) AMINO-DL-PHENYLALANINE (ORTHOSARCOLYSIN)].
Topics: Antineoplastic Agents; Melphalan; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenylalanine; Rats; Research; Toxicology | 1964 |
[Anti-tumor action of p-bis (chloroethyl) aminophenylalanine (sarcolysin)].
Topics: Animals; Melphalan; Neoplasms; Neoplasms, Experimental; Phenylalanine | 1955 |
Some experimental and clinical data on the sarcolysin peptides.
Topics: Melphalan; Neoplasms; Peptides; Phenylalanine | 1960 |
[The effect of sarocolysin on regeneration in amphibia and tumors in mice in conditions of light hypothermia].
Topics: Amphibians; Animals; Hypothermia; Hypothermia, Induced; Light; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Regeneration | 1960 |
Effects of beta-3-thienylalanine and deoxypyridoxine on the tumor growth. II. Effects on the tumor-bearing host.
Topics: Animals; Neoplasms; Neoplasms, Experimental; Phenylalanine; Vitamin B 6 | 1962 |
Salt inhibition and enhancement of cytochrome, succinic, and dopa oxidase systems of mouse melanomas.
Topics: Cytochromes; Melanoma; Monophenol Monooxygenase; Neoplasms; Oxidoreductases; Phenylalanine; Salts | 1950 |
Study on the compounds containing 19F and 10B atoms in a single molecule for the application to MRI and BNCT.
Topics: Animals; Boron; Boron Neutron Capture Therapy; Boronic Acids; Cell Line, Tumor; Cells, Cultured; Contrast Media; Fluorine; HeLa Cells; Humans; Isotopes; Magnetic Resonance Imaging; Molecular Structure; Neoplasms; Phenylalanine; Rats | 2006 |
Identification of p53-46F as a super p53 with an enhanced ability to induce p53-dependent apoptosis.
Topics: Adenoviridae; Amino Acid Substitution; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Genetic Therapy; Humans; Mice; Mutation; Neoplasms; Phenylalanine; Phosphorylation; Protein Biosynthesis; Proto-Oncogene Proteins c-bcl-2; Serine; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases | 2006 |
Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
Topics: Amino Acids; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Copper; Drug Design; Humans; Iodine Radioisotopes; Isotope Labeling; Models, Chemical; Neoplasms; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Temperature | 2006 |
Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Topics: Active Transport, Cell Nucleus; Amino Acid Sequence; Animals; Cell Nucleus; Cysteine; HeLa Cells; Humans; Mice; Molecular Sequence Data; Mutant Proteins; Mutation; Neoplasms; Phenylalanine; Protein Binding; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-mdm2; Ribosomal Proteins; Transcription, Genetic; Tumor Suppressor Protein p53; Ubiquitin; Zinc Fingers | 2007 |
Mutations in JAK2V617F homologous domain of JAK genes are uncommon in solid tumors.
Topics: Base Sequence; Conserved Sequence; Humans; Janus Kinase 2; Mutation; Neoplasms; Phenylalanine; Protein Structure, Tertiary; Valine | 2007 |
Convergence of isoenzyme expression in human tumor xenografts.
Topics: Alkaline Phosphatase; Animals; Cell Line; Cricetinae; Homoarginine; Humans; Isoenzymes; Neoplasm Transplantation; Neoplasms; Phenylalanine; Stereoisomerism; Transplantation, Heterologous | 1980 |
Determination of urinary amino acids by liquid chromatography with "dabsyl chloride".
Topics: Amino Acids; Chromatography, Liquid; Humans; Neoplasms; p-Dimethylaminoazobenzene; Phenylalanine; Phenylketonurias; Sulfones | 1980 |
Characterization and use of an allotype-specific monoclonal antibody to placental alkaline phosphatase in the study of cancer-related phosphatase polymorphism.
Topics: Alkaline Phosphatase; Alleles; Animals; Antibodies, Monoclonal; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hybridomas; Kinetics; Leucine; Mice; Mice, Inbred BALB C; Neoplasms; Phenotype; Phenylalanine; Placenta; Polymorphism, Genetic; Pregnancy | 1982 |
[Curing trial of complicated oncologic pain by D-phenylalanine (author's transl)].
Topics: Affect; Aged; Analgesics; Drug Evaluation; Enkephalins; Female; Humans; Male; Middle Aged; Neoplasms; Pain, Intractable; Phenylalanine | 1981 |
Skin sensitization with the new reagents NOPYE (4-nitro-1-cyclohexyl-3-ethoxy-2-oxo-3-pyrroline) and NOPY-L-phenylalanine.
Topics: Adjuvants, Immunologic; Animals; Cross Reactions; Cyclohexanes; Dinitrochlorobenzene; Female; Guinea Pigs; Hypersensitivity, Delayed; Immunotherapy; Neoplasms; Ovalbumin; Phenylalanine; Pyrroles; Skin; Tuberculin | 1980 |
Matrix metalloproteinase inhibitors: a novel class of anticancer agents.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Female; Humans; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1995 |
Maximum therapeutic depth in thermal neutron capture therapy.
Topics: Boranes; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Humans; Neoplasms; Phenylalanine; Sulfhydryl Compounds | 1993 |
Expression and characterization of human pancreatic preprocarboxypeptidase A1 and preprocarboxypeptidase A2.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carboxypeptidases; Cattle; Cloning, Molecular; DNA Primers; Enzyme Precursors; Enzyme Stability; Gene Expression; Humans; Kinetics; Methotrexate; Molecular Sequence Data; Neoplasms; Pancreas; Phenylalanine; Prodrugs; Rats; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Substrate Specificity; Temperature | 1996 |
Whole body protein metabolism in children with cancer.
Topics: Adolescent; Amino Acids; Carbon Isotopes; Child; Child, Preschool; Deuterium; Female; Humans; Kinetics; Leucine; Male; Neoplasms; Phenylalanine; Protein Biosynthesis; Proteins; Tyrosine | 1996 |
Batimastat. BB 94, collagenase inhibitors-1.
Topics: Animals; Antineoplastic Agents; Ascites; Drugs, Investigational; Humans; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Mice; Neoplasms; Phenylalanine; Pleural Effusion, Malignant; Protease Inhibitors; Thiophenes | 1999 |
Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.
Topics: Enzyme Activation; Humans; Hydrogen-Ion Concentration; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Membrane Proteins; Metalloendopeptidases; Neoplasms; Phenylalanine; Protease Inhibitors; Recombinant Proteins; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured | 2000 |
Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets.
Topics: Adult; Blood Platelets; Cell Division; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Fibroblast Growth Factor 2; Flow Cytometry; Humans; Lymphokines; Microscopy, Fluorescence; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Piperidines; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Thrombin; Thrombophilia; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
Topics: Animals; Apoptosis; Hepatitis, Animal; Humans; Interferon-gamma; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Phenylalanine; Protease Inhibitors; Recombinant Proteins; Thiophenes; Tumor Necrosis Factor-alpha | 2001 |
Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Topics: Animals; Apoptosis; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cadmium; Carcinoma, Squamous Cell; Cytochalasin B; Fluorescent Antibody Technique; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Micronucleus Tests; Neoplasms; Neutrons; Phenylalanine; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Radioisotopes; Relative Biological Effectiveness; Sarcoma, Experimental; Sulfhydryl Compounds; Tumor Cells, Cultured | 2001 |
A modified inactivation-inhibition method for determining the serum activity of alkaline phosphatase isoenzymes.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Evaluation Studies as Topic; gamma-Glutamyltransferase; Humans; Intestines; Isoenzymes; Liver; Liver Diseases; Methods; Middle Aged; Neoplasms; Organ Specificity; Phenylalanine | 1976 |
[Distribution of T and B lymphocytes in children's diseases. M. Down, phenylketonuria, celiac disease and other malabsorptions, malignant tumours, chronic otitis media, and infectious mononucleosis (author's transl)].
Topics: Age Factors; B-Lymphocytes; Celiac Disease; Child; Down Syndrome; Humans; Infectious Mononucleosis; Leukocyte Count; Malabsorption Syndromes; Neoplasms; Phenylalanine; Phenylketonurias; T-Lymphocytes | 1979 |
[Experimental and clinical application of amino acid imbalance for the treatment of malignant diseases, with special reference to phenylalanine imbalance (author's transl)].
Topics: Adult; Amino Acids; Animals; Blood Cell Count; Carcinoma, Ehrlich Tumor; Child; Female; Humans; Leucine; Leukemia, Myeloid; Liver; Male; Mice; Neoplasm Proteins; Neoplasms; Organ Size; Phenylalanine; Phenylalanine Hydroxylase | 1977 |
[Tumour chemotherapy. XXXIX Synthesis of 2-methyl-5-bis (beta-chloroethyl) aminophenylalanine and 2-bis (beta-chloroethyl)-aminomethyl-5-nitrophenylalanine (author's transl)].
Topics: Animals; Antineoplastic Agents; Melphalan; Mice; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine | 1979 |
On the levels of phenylalanine, tyrosine and tetrahydrobiopterin in the blood of tumor-bearing organisms.
Topics: Animals; Biopterins; Blood Proteins; Female; Humans; Hydroxylation; Male; Neoplasms; Neoplasms, Experimental; Phenylalanine; Protein Binding; Pteridines; Rats; Tyrosine | 1977 |
Drugs that make cancer retreat.
Topics: Antineoplastic Agents; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine; Piperazines; Prospidium; Tegafur | 1976 |
L-leucine sensitive alkaline phosphatase isozyme from cancer tissue.
Topics: Alkaline Phosphatase; Drug Stability; Edetic Acid; Female; Hot Temperature; Humans; Isoenzymes; Kinetics; Leucine; Neoplasms; Phenylalanine; Placenta; Precipitin Tests; Pregnancy | 1975 |
Aminopeptidases and arylamidases in normal and cancer tissues in humans.
Topics: Alanine; Amides; Aminopeptidases; Colon; Digestive System; Humans; Ileum; Kidney; Leucine; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Methionine; Naphthalenes; Neoplasms; Phenylalanine; Rectum; Stomach; Stomach Neoplasms | 1975 |
Intracellular boron localization and uptake in cell cultures using imaging secondary ion mass spectrometry (ion microscopy) for neutron capture therapy for cancer.
Topics: Animals; Boron Compounds; Cryopreservation; Mass Spectrometry; Mice; Microscopy; Neoplasms; Neutrons; Phenylalanine; Tumor Cells, Cultured; Uridine | 1992 |
[Anticancer therapy with amino acid imbalance].
Topics: Amino Acids; Animals; Antineoplastic Agents; Arginine; Cysteine; Humans; Methionine; Neoplasms; Parenteral Nutrition, Total; Phenylalanine; Tyrosine; Valine | 1991 |
Boron neutron capture therapy for cancer.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Boron; Boron Compounds; Brain Neoplasms; Glioblastoma; Humans; Immunotoxins; Isotopes; Melanoma; Mice; Neoplasms; Neutrons; Phenylalanine; Radiation Dosage | 1990 |
Preparation of boron-containing bovine -globulin as a model compound for a new approach to slow neutron therapy of tumors.
Topics: Alanine; Anhydrides; Animals; Boron Compounds; Boronic Acids; Cattle; Chromatography, Gel; Dipeptides; gamma-Globulins; Methods; Neoplasms; Neutrons; Phenylalanine | 1972 |
[Antitumor activity of nitrocaphane (AT-1258)].
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Nitrogen Mustard Compounds; Phenylalanine; Rats | 1974 |
The potential of coenzyme Q 10 (NSC-140865) in cancer treatment.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Chick Embryo; Cricetinae; Haplorhini; Humans; Lipid Metabolism; Metabolism, Inborn Errors; Mice; Neoplasms; Peroxides; Phenylalanine; Rabbits; Rats; Sarcoma 180; Succinate Dehydrogenase; Turkeys; Tyrosine; Ubiquinone | 1974 |
Effects of phenylalanine and related compounds on serum alkaline phosphatase assay.
Topics: Adult; Alkaline Phosphatase; Bone Diseases; Chemistry, Clinical; Chloramphenicol; Fenclonine; Humans; Liver Diseases; Melphalan; Neoplasms; Phenylalanine; Phenylketonurias; Stereoisomerism | 1971 |
Clinical application of phosphohydrolase measurements in cancer.
Topics: Acid Phosphatase; Alkaline Phosphatase; Bile Acids and Salts; Bone Neoplasms; Electrophoresis; Histidine; Humans; Hydrogen-Ion Concentration; Kidney; Liver; Male; Neoplasms; Nucleotidases; Organ Specificity; Phenylalanine; Phosphoric Monoester Hydrolases; Prostatic Neoplasms | 1969 |
New diet 'starves' cancer cells.
Topics: Diet Therapy; Humans; Neoplasms; Phenylalanine | 1967 |
Peptichemio in the therapy of malignancies (phase-I-study). The evaluation committee.
Topics: Blood Platelets; Bone Marrow Diseases; Cell Division; Cell Membrane; Chromosomes; Drug Evaluation; Humans; Immunosuppressive Agents; Lymphoma; Microscopy, Electron; Neoplasms; Nitrogen Mustard Compounds; Peptides; Phenylalanine; Thymidine; Time Factors; Tritium | 1974 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Cattle; Depression, Chemical; DNA, Neoplasm; Female; Fluorouracil; Humans; In Vitro Techniques; Iodoacetates; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Mice; Neoplasms; Phenylalanine; Succinate Dehydrogenase; Thymidine; Tritium | 1974 |
Problems of in-vitro incubation with radioactive precursors.
Topics: Animals; Antineoplastic Agents; Cytidine; Humans; Neoplasms; Phenylalanine; Proline; Rats; Thymidine; Tritium | 1973 |
Presented before the OSHA hearings regarding proposed permanent standard on certain carcinogens.
Topics: Animals; Biphenyl Compounds; Carcinogens; Chemical Industry; Chlorine; Cricetinae; Environmental Exposure; Female; Follow-Up Studies; Humans; Lethal Dose 50; Male; Mice; Neoplasms; Nitrogen Mustard Compounds; Occupational Diseases; Phenols; Phenylalanine; Phenylbutyrates; Rabbits; Rats; Sampling Studies; Statistics as Topic; United States; Urinary Bladder Neoplasms | 1974 |
Transfer RNA methylases and cancer.
Topics: Animals; Carbon Isotopes; Carcinogens; Cell Differentiation; Chromatography, Ion Exchange; Escherichia coli; Ethionine; Guanine; Humans; Kidney Neoplasms; Liver Regeneration; Methionine; Methylation; Morphogenesis; Neoplasms; Nitrosamines; Phenylalanine; Protein Biosynthesis; Rats; Ribosomes; RNA, Bacterial; RNA, Messenger; RNA, Transfer; Transferases | 1970 |
The clinical usefulness of alkaline phosphatase isoenzyme determinations.
Topics: Alkaline Phosphatase; Bone Diseases; Clinical Enzyme Tests; Electrophoresis, Disc; Hot Temperature; Intestinal Diseases; Isoenzymes; Kidney Diseases; Liver Diseases; Methods; Neoplasms; Phenylalanine; Tissue Extracts; Urea | 1972 |
[Concentration changes of free amino acids in blood plasma of patients under radiotherapy. (With reference to statistical results)].
Topics: Alanine; Amino Acids; Bronchial Neoplasms; Carcinoma; Cobalt Isotopes; Dysgerminoma; Esophageal Neoplasms; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leucine; Male; Neoplasms; Phenylalanine; Proline; Radiation Injuries; Sex Factors; Statistics as Topic; Tyrosine; Urinary Bladder Neoplasms; Valine | 1972 |
Patterns of amino-acid inhibition of alkaline phosphatases as an aid in cancer diagnosis.
Topics: Adenocarcinoma; Alanine; Alkaline Phosphatase; Amino Acids; Animals; Arginine; Colonic Neoplasms; Female; Humans; In Vitro Techniques; Isoenzymes; Lung Neoplasms; Mammary Neoplasms, Experimental; Neoplasms; Phenylalanine; Rats; Valine | 1971 |
The early interference of liver carcinogens with protein synthesis and its possible bearing on the problem of tumor induction.
Topics: Acridines; Animals; Carbon Isotopes; Carbon Tetrachloride; Carcinogens; Centrifugation, Density Gradient; Chromatography, Gel; Electrophoresis, Disc; In Vitro Techniques; Liver; Macromolecular Substances; Mice; Microsomes, Liver; Neoplasms; Orotic Acid; Peptide Chain Initiation, Translational; Phenylalanine; Potassium Chloride; Protein Biosynthesis; Rats; Ribosomes; RNA; RNA, Messenger | 1971 |
Clinical application of alkaline phosphatase isoenzyme analysis.
Topics: Alkaline Phosphatase; Bile Acids and Salts; Bone Neoplasms; Electrophoresis; Histidine; Hot Temperature; Humans; Hydrogen-Ion Concentration; Isoenzymes; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasms; Nucleotidases; Phenylalanine; Protein Denaturation | 1969 |
Studies in histochemistry. LXXIX. Properties of tryptophan hydroxylase from neoplastic murine mast cells.
Topics: 5-Hydroxytryptophan; Animals; Autoradiography; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Mast Cells; Mice; Mixed Function Oxygenases; Neoplasms; Phenylalanine; Serotonin; Tryptophan | 1966 |
Alkaline phosphatase in meningiomas.
Topics: Alkaline Phosphatase; Central Nervous System Diseases; Chemical Phenomena; Chemistry, Physical; Hot Temperature; Humans; Meningioma; Neoplasms; Phenylalanine; Urea | 1970 |
Automated differential isoenzyme analysis. I. L-phenylalanine-sensitive isoenzymes of human serum alkaline phosphatase.
Topics: Alkaline Phosphatase; Autoanalysis; Bone Diseases; Female; Humans; Indicators and Reagents; Intestinal Absorption; Intestines; Isoenzymes; Liver Diseases; Methods; Neoplasms; Phenylalanine; Placenta; Pregnancy; Spectrophotometry | 1967 |
Dietary amino acid and nucleic acid imbalance leading to altered tumour frequency in the adult housefly, Musca domestica.
Topics: Aging; Amino Acids; Animals; Dietary Proteins; Houseflies; Neoplasms; Nucleic Acids; Phenylalanine | 1968 |
[Relations between phenylalanine and cancerous cells].
Topics: Amino Acids; Animals; Diet Therapy; Humans; Neoplasms; Phenylalanine; Proteins; Tyrosine | 1968 |
[A novel synthesis of o-methoxy-p-[bis-(2-chloroethyl)-amino]-phenylalanine].
Topics: Chemistry, Pharmaceutical; Humans; Neoplasms; Phenylalanine | 1966 |